NHS Blood and Transplant's Therapeutic Apheresis Services (TAS) and Cellular and Molecular Therapies (CMT) teams are ...
Formation Bio today announced that Anirvan Ghosh, PhD, has joined the company as SVP, Head of Translational Sciences. Ghosh ...
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Dean Merder to serve as Executive Advisor to the Chairman, following eight years of leadership. WASHINGTON, Ind.--(BUSINESS ...
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...
TORONTO, Oct. 8, 2026 /CNW/ -- Apotex Health Corp. ("Apotex") (TSX: APTX) today announced that it will issue a press release ...
Publication of the peer-reviewed papers comes as iOnctura awaits readouts from its two fully-enrolled, randomized Phase II ...
Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbers
For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 ...
Tevogen is also actively considering other transactions with a focus on life sciences and healthcare-related businesses; ...
The new NCCN Guidelines for the Philippines reflect close collaborations between NCCN and PSMO, as well as with the Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results